Prelude Capital Management’s LENZ Therapeutics LENZ Stock Holding History

Prelude Capital Management’s Portfolio LENZ Stock Details LENZ Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.72M	Buy
2024 Q1	–	Sell
2023 Q4	$74.9K	Sell
2023 Q3	$71.6K	Sell
2023 Q2	$105K	Buy
2023 Q1	$78.6K	Sell
2022 Q4	$114K	Buy
2022 Q3	$104K	Buy
2022 Q2	$67K	Buy